Lead Plaintiffs Seek Class Certification In Puma Biotech Securities Suit

(March 16, 2017, 4:14 PM EDT) -- SANTA ANA, Calif. — Lead plaintiffs in a securities class action lawsuit against a drug maker and certain of its executive officers asked a federal judge in California on March 15 to certify a class of investors, arguing that class certification is statutorily appropriate (Hsingching Hsu v. Puma Biotechnology Inc., et al., No. 15-0865, C.D. Calif.)....